Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v9-FR
Language French French
Date Updated 2024-04-02 2024-03-05
Drug Identification Number 02526883 02526883
Brand name SANDOZ AMBRISENTAN TABLETS SANDOZ AMBRISENTAN TABLETS
Common or Proper name AMBRISENTAN TABLETS AMBRISENTAN TABLETS
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients AMBRISENTAN AMBRISENTAN
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 10MG 30FCT 10MG 30FCT
ATC code C02KX C02KX
ATC description OTHER ANTIHYPERTENSIVES OTHER ANTIHYPERTENSIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-05 2024-02-05
Estimated end date 2024-04-12 2024-03-15
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments